Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

The 4th U.S. Circuit Court of Appeals on Thursday blocked the enforcement of the Trump administration's rules that prohibit taxpayer-funded family planning clinics under the Title X program in Maryland from providing or making abortion referrals.

Why it matters: Thursday's decision in the Virginia-based federal court is at odds with a ruling in the California-based 9th U.S. Circuit Court of Appeals, which upheld the rules and allowed them to take effect. The division means the Supreme Court may be more likely to take up the issue.

What they're saying: The 4th U.S. Circuit Court of Appeals ruled that the Trump administration "failed to recognize and address the ethical concerns of literally every major medical organization in the country," and "arbitrarily estimated the cost" to clinics in implementing the rules.

Context: Title X is a $286 million federal family planning program that primarily serves low-income individuals.

  • Last year, Planned Parenthood and some states withdrew from the program to avoid complying with the Trump administration's rule changes.
  • Abortion rights supporters have referred to the changes as a "gag rule," saying the orders hurt the relationship between women and their doctors, who have to limit the information they can provide. They also say the rules would force some abortion providers to shut down or undergo expensive remodels, hurting access to reproductive health services broadly.
  • Abortion rights opponents have long argued that the Title X program indirectly subsidizes abortion services. Providers were already barred from using federal funds for abortion services.

Of note: Thursday's decision, which involved a lawsuit by Baltimore's mayor and city council, only applies to the state of Maryland.

  • "Today’s ruling will continue to prevent this terrible rule from further harming family planning providers and their patients across the state of Maryland. Unfortunately, the court did not take the opportunity to bring the desperately needed relief to the nationwide family planning provider network that is appropriate under and required by federal law," Clare Coleman, president and CEO of the National Family Planning & Reproductive Health Association, said in a statement.

Go deeper: Read the 4th U.S. Circuit Court of Appeals' ruling.

Go deeper

Ben Geman, author of Generate
Sep 24, 2020 - Energy & Environment

California war over gas-free cars

Illustration: Eniola Odetunde/Axios

The fate of California's aggressive moves to wring carbon emissions out of transportation could depend heavily on the election and the shape of the Supreme Court.

Why it matters: California is the country's largest auto market and transportation is the country's largest source of CO2.

Caitlin Owens, author of Vitals
16 mins ago - Health

Why waiving vaccine patents might be a bad idea

Illustration: Aïda Amer/Axios

It will take more than waiving patent protections for coronavirus vaccines — which the Biden administration now says it supports — to fix the gaping global divide in access.

Why it matters: Waiving drug companies' intellectual property rights risks setting a bad precedent for future investment in new drugs. And that risk may not be worth it without additional steps to meaningfully increase the availability of shots across the world.

Coronavirus cases hit a seven-month low

Expand chart
Data: CSSE Johns Hopkins University; Map: Andrew Witherspoon/Axios

Coronavirus infections in the U.S. are now at their lowest levels in seven months, thanks to the vaccines.

The big picture: The vaccines are turning the tide in America's battle with the coronavirus. Deaths and serious illnesses have dropped significantly, and now cases are falling too — an important piece of protection for the future, if we can keep it up.

You’ve caught up. Now what?

Sign up for Mike Allen’s daily Axios AM and PM newsletters to get smarter, faster on the news that matters.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!